Amylyx Pharmaceuticals (AMLX) Work In Process (2022)
Amylyx Pharmaceuticals (AMLX) posted quarterly Work In Process of $1.7 million for Q4 2022, up 3635.56% quarter-over-quarter from $45000.0 in Q3 2022.
Amylyx Pharmaceuticals (AMLX) Work In Process (2022) Analysis & Trends
Amylyx Pharmaceuticals' Work In Process history runs 1 years deep, the most recent figure standing at $1.7 million for Q4 2022.
- In Q4 2022, Work In Process changed N/A year-over-year to $1.7 million; the TTM figure through Dec 2022 stood at $1.7 million (changed N/A YoY), while the FY2022 annual figure was $1.7 million, changed N/A from the prior year.
- Work In Process for Q4 2022 stood at $1.7 million, up from $45000.0 in the prior quarter.
- The five-year high for Work In Process was $1.7 million in Q4 2022, with the low at $45000.0 in Q3 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 86.50 Bn | 85.53 Bn | - |
| 2 | Teva Pharmaceutical Industries | 42.71 Bn | 39.05 Bn | 2.15 Bn |
| 3 | Zoetis | 30.86 Bn | 29.18 Bn | 1.80 Bn |
| 4 | Takeda Pharmaceutical | 28.50 Bn | 22.70 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.06 Bn | 19.40 Bn | 683.80 Mn |
| 6 | Viatris | 18.84 Bn | 17.95 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.55 Bn | 15.16 Bn | 935.80 Mn |
| 8 | Vireo Growth | 11.86 Bn | 11.71 Bn | 59.30 Mn |
| 9 | Elanco Animal Health | 11.77 Bn | 11.24 Bn | 798.00 Mn |
| 10 | Amylyx Pharmaceuticals | 3.91 Bn | 3.91 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2022 | 1.68 Mn |
| Sep 30, 2022 | 45,000.00 |